| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/15/2004 | US20040137599 Leporipox-based vector vaccines |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137513 Agonist anti-trk-c monoclonal antibodies |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137487 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target |
| 07/15/2004 | US20040137485 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137437 Human source leading sequence, gene vector and gene expression strategy |
| 07/15/2004 | US20040137423 Compositions and methods for modulating HDL cholesterol and triglyceride levels |
| 07/15/2004 | US20040137050 Linear polyethylenimine-sterol conjugates for gene delivery |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040137003 Regulated antigen delivery system (rads) |
| 07/15/2004 | US20040136978 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 07/15/2004 | US20040136973 Human stem cell materials and methods |
| 07/15/2004 | US20040136967 Cultures, products and methods using stem cells |
| 07/15/2004 | US20040136963 Simian adenovirus vectors and methods of use |
| 07/15/2004 | US20040136960 sphygmomanometer is used to apply pressure to mammalian skin, around a limb, for the purpose of increasing vessel permeability when combined with solution injection into the vessel |
| 07/15/2004 | US20040136959 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il -13 receptor alpha chain |
| 07/15/2004 | US20040136948 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | CA2511625A1 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | CA2510503A1 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 07/15/2004 | CA2510362A1 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | CA2508985A1 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | CA2505842A1 Translational control by small, non-translatable rnas |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1437593A1 Method of examining (-)-strand rna virus vector having lowered ability to form grains and method of constructing the same |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436403A2 Use of the adenoviral e2 late promoter |
| 07/14/2004 | EP1436400A1 Multi-cistronic vectors for gene transfer protocols |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436392A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436389A2 Thrombin-cleavable chimeric proteins |
| 07/14/2004 | EP1436330A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436316A2 Subcellular targeting of therapeutic proteins |
| 07/14/2004 | EP1436313A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/14/2004 | EP1436308A2 Antisense modulation of il-1 receptor-associated kinase-4 expression |
| 07/14/2004 | EP1436014A1 Cationic lipids suitable for gene transfer |
| 07/14/2004 | EP1436013A2 Method for inducing growth and enhancing survival of nervous tissue |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435973A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |
| 07/14/2004 | EP1372689B1 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 07/14/2004 | CN1157184C Application of liposome preparation in transferring foreign DNA by testis injection |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762169 Improved transmembrane delivery of nucleosides conjugated to an arylpropionic acid ligand (ibuprofen) which has affinity for plasma protein albumin; antisense therapy |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6761909 Compressed antisolvent fluid precipitates particles; organic cosolvent system; biocompatible polymer for pulmonary sustained insulin release; inhalant powder; solvent extraction |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761892 Heat shock protein-based vaccines and immunotherapies |
| 07/13/2004 | US6761882 Helical cytokine zalpha33 |
| 07/08/2004 | WO2004057017A2 Detection of small nucleic acids |
| 07/08/2004 | WO2004057006A1 Genetic therapy and genetic modification using neocentromeric minichromosomes |
| 07/08/2004 | WO2004057005A1 Vectors lacking an origin of replication functioning in mammalian cells and expressing growth factors |
| 07/08/2004 | WO2004056979A2 Recombinant virus production for the manufacturing of vaccines |
| 07/08/2004 | WO2004056977A1 Production of alvac on avian embryonic stem cells |
| 07/08/2004 | WO2004056966A2 Methods of inhibiting gene expression by rna interference |
| 07/08/2004 | WO2004056176A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 07/08/2004 | WO2004035779A8 Biomolecule transfer method using virus envelope and composition and system therefor |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004034966A3 Substances for preventing and treating autoimmune diseases |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004018010A3 Methods of drug delivery using sulphated chitinous polymers |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2004003170A3 Agents capable of inhibiting ras and uses thereof |
| 07/08/2004 | WO2003099213A3 Method for reducing platelet count |
| 07/08/2004 | WO2003097687A3 Neuroprotective polypeptides and methods of use |
| 07/08/2004 | WO2003092598A3 Treatment for pompe disease |
| 07/08/2004 | WO2003090676A3 Immunogenic agent therapy using plasmapheresis or exchange transfusion |
| 07/08/2004 | WO2003089600A3 Surface transfection and expression procedure |
| 07/08/2004 | WO2003079757A3 Hiv therapeutic |
| 07/08/2004 | WO2003077871A3 Method of diagnosis and treatment of breast lesions |
| 07/08/2004 | WO2003074565A3 Peptides for use in antitumor immunotherapy |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | US20040133933 Medane genes and proteins |
| 07/08/2004 | US20040132974 Cell adhesion polypeptide for use tools in diagnosis, prevention and treatment of cardiovascular, cell proliferative, ischemic, restenotic, blood and gastrointestinal disorders |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132972 Tri-hybrid melanoma antigen |
| 07/08/2004 | US20040132968 Novel bag proteins and nucleic acid molecules encoding them |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132683 Expression of exogenous polynucleotide sequences in a vertebrate |
| 07/08/2004 | US20040132681 Antisense modulation of beta-site APP-cleaving enzyme 2 expression |